As Valeant Pharmaceuticals Intl (VRX) Share Price Declined, Stanley Capital Management Upped by $564,400 Its Stake; As Cardinal Health (CAH) Stock Declined, Holder Zwj Investment Counsel Has Raised Stake

December 19, 2017 - By Marie Mckinney

Zwj Investment Counsel Inc increased its stake in Cardinal Health Inc (CAH) by 4.94% based on its latest 2017Q2 regulatory filing with the SEC. Zwj Investment Counsel Inc bought 15,750 shares as the company’s stock declined 8.93% while stock markets rallied. The institutional investor held 334,501 shares of the health care company at the end of 2017Q2, valued at $26.06 million, up from 318,751 at the end of the previous reported quarter. Zwj Investment Counsel Inc who had been investing in Cardinal Health Inc for a number of months, seems to be bullish on the $19.63 billion market cap company. The stock decreased 1.27% or $0.8 during the last trading session, reaching $62.39. About 4.36M shares traded or 28.26% up from the average. Cardinal Health, Inc. (NYSE:CAH) has declined 4.95% since December 19, 2016 and is downtrending. It has underperformed by 21.65% the S&P500.

Stanley Capital Management Llc increased its stake in Valeant Pharmaceuticals Intl (VRX) by 21.38% based on its latest 2017Q2 regulatory filing with the SEC. Stanley Capital Management Llc bought 33,200 shares as the company’s stock declined 15.71% while stock markets rallied. The institutional investor held 188,500 shares of the health care company at the end of 2017Q2, valued at $3.26 million, up from 155,300 at the end of the previous reported quarter. Stanley Capital Management Llc who had been investing in Valeant Pharmaceuticals Intl for a number of months, seems to be bullish on the $7.38B market cap company. The stock increased 7.56% or $1.49 during the last trading session, reaching $21.2. About 27.03 million shares traded or 63.11% up from the average. Valeant Pharmaceuticals International, Inc. (NYSE:VRX) has declined 48.51% since December 19, 2016 and is downtrending. It has underperformed by 65.21% the S&P500.

Among 27 analysts covering Valeant Pharmaceuticals Intl (NYSE:VRX), 6 have Buy rating, 5 Sell and 16 Hold. Therefore 22% are positive. Valeant Pharmaceuticals Intl had 148 analyst reports since July 21, 2015 according to SRatingsIntel. The rating was downgraded by JP Morgan on Thursday, December 14 to “Underweight”. As per Tuesday, August 29, the company rating was maintained by Cantor Fitzgerald. As per Wednesday, March 16, the company rating was maintained by JP Morgan. Piper Jaffray maintained the stock with “Sell” rating in Friday, September 15 report. BTIG Research maintained Valeant Pharmaceuticals International, Inc. (NYSE:VRX) on Thursday, November 9 with “Hold” rating. The firm has “Sector Perform” rating by IBC given on Monday, November 30. The firm has “Buy” rating by Rodman & Renshaw given on Wednesday, March 16. Jefferies maintained the stock with “Buy” rating in Wednesday, March 16 report. The firm has “Hold” rating by H.C. Wainwright given on Wednesday, October 4. Morgan Stanley maintained it with “Equal-Weight” rating and $98.0 target in Tuesday, November 17 report.

Investors sentiment decreased to 1.08 in 2017 Q2. Its down 0.16, from 1.24 in 2017Q1. It dropped, as 53 investors sold VRX shares while 76 reduced holdings. 49 funds opened positions while 90 raised stakes. 171.89 million shares or 1.47% more from 169.41 million shares in 2017Q1 were reported. Cubist Systematic Strategies Llc holds 600 shares. Invesco has invested 0.01% of its portfolio in Valeant Pharmaceuticals International, Inc. (NYSE:VRX). Intact Mngmt stated it has 0.15% of its portfolio in Valeant Pharmaceuticals International, Inc. (NYSE:VRX). Bessemer holds 0% or 1,225 shares. Community Tru Inv invested in 0.05% or 25,095 shares. Alpine Glob Ltd Liability holds 0.54% of its portfolio in Valeant Pharmaceuticals International, Inc. (NYSE:VRX) for 100,000 shares. Exchange Cap Mngmt stated it has 0% in Valeant Pharmaceuticals International, Inc. (NYSE:VRX). State Bank Of Mellon Corp reported 348,751 shares. Biglari Cap, Texas-based fund reported 395,000 shares. Chou Associates Mngmt stated it has 3.05 million shares or 16.38% of all its holdings. Benjamin F Edwards Inc accumulated 99 shares. Fmr invested in 170,670 shares. Jw Asset Mngmt Ltd Llc has 0.71% invested in Valeant Pharmaceuticals International, Inc. (NYSE:VRX). Vanguard Group has invested 0.01% in Valeant Pharmaceuticals International, Inc. (NYSE:VRX). Dimensional Fund Lp holds 0.01% or 1.05 million shares.

Zwj Investment Counsel Inc, which manages about $1.35B and $1.25B US Long portfolio, decreased its stake in Pepsico Inc (NYSE:PEP) by 3,946 shares to 25,050 shares, valued at $2.89M in 2017Q2, according to the filing. It also reduced its holding in Aflac Inc (NYSE:AFL) by 36,205 shares in the quarter, leaving it with 7,925 shares, and cut its stake in Exxon Mobil Corp (NYSE:XOM).

Among 20 analysts covering Cardinal Health (NYSE:CAH), 5 have Buy rating, 1 Sell and 14 Hold. Therefore 25% are positive. Cardinal Health had 43 analyst reports since August 10, 2015 according to SRatingsIntel. The firm has “Market Perform” rating given on Wednesday, January 6 by Raymond James. UBS maintained Cardinal Health, Inc. (NYSE:CAH) on Tuesday, November 3 with “Buy” rating. The stock has “Neutral” rating by Mizuho on Tuesday, January 3. The stock of Cardinal Health, Inc. (NYSE:CAH) earned “Buy” rating by Cowen & Co on Tuesday, October 10. On Tuesday, June 7 the stock rating was maintained by Bank of America with “Neutral”. Jefferies maintained the shares of CAH in report on Thursday, July 27 with “Hold” rating. The firm has “Hold” rating given on Tuesday, October 24 by Mizuho. The rating was maintained by Credit Suisse on Thursday, July 13 with “Buy”. Cowen & Co downgraded Cardinal Health, Inc. (NYSE:CAH) on Tuesday, March 15 to “Market Perform” rating. The firm earned “Buy” rating on Thursday, December 17 by Goldman Sachs.

Investors sentiment increased to 0.87 in Q2 2017. Its up 0.03, from 0.84 in 2017Q1. It improved, as 58 investors sold CAH shares while 247 reduced holdings. 62 funds opened positions while 202 raised stakes. 273.65 million shares or 1.23% more from 270.34 million shares in 2017Q1 were reported. First United National Bank Trust reported 9,095 shares. Peninsula Asset accumulated 1.39% or 23,855 shares. Aperio Gp Ltd Co holds 0.06% or 122,301 shares. Country Trust Commercial Bank has 1% invested in Cardinal Health, Inc. (NYSE:CAH). Retail Bank Of Nova Scotia accumulated 0.04% or 105,357 shares. Lpl Financial Ltd Liability Corp holds 0.01% or 42,089 shares in its portfolio. Smith Graham & Company Advisors Lp reported 38,520 shares. Rockland Trust reported 12,296 shares. Bokf Na has invested 0.02% in Cardinal Health, Inc. (NYSE:CAH). First Mercantile Tru Company stated it has 2,289 shares. 60,893 were reported by M&T Savings Bank. 2,652 were reported by Umb National Bank & Trust N A Mo. Moreover, Private Bancorp has 0.13% invested in Cardinal Health, Inc. (NYSE:CAH) for 12,336 shares. Strs Ohio has invested 0.13% in Cardinal Health, Inc. (NYSE:CAH). Archford Capital Strategies Ltd Liability Company, Illinois-based fund reported 289 shares.